![Charles McDermott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 76 157 $ al 30/06/2026
Charles McDermott is President, Chief Executive Officer & Director at Primmune Therapeutics, Inc. since 2019.
Mr. McDermott is Chairman at Anavo Therapeutics BV.
Mr. McDermott is Independent Director at Equillium, Inc. since 2018.
Mr. McDermott is Managing Member at McDermott Consulting since 2018.
Formerly, Mr. McDermott was Director, VP-Business Development & Eye Care at Allergan, Inc. from 2005 to 2013.
Mr. McDermott was President, Director & Chief Business Officer at Impact Biomedicines, Inc. from 2017 to 2018.
Mr. McDermott was Research Scientist at Agouron Pharmaceuticals LLC.
Mr. McDermott was Principal at deCODE genetics, Inc. from 2001 to 2005.
Mr. McDermott was President & Chief Business Officer at Kala Bio, Inc. from 2014 to 2017.
Education includes graduate studies at the University of California, Santa Barbara, undergraduate studies at the University of California, Santa Cruz, and an MBA from the University of San Diego.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EQUILLIUM, INC. 0,04 % | 28/05/2026 | 23.799 ( 0,04 % ) | 76 157 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EQUILLIUM, INC. | Director/Miembro de la Junta | 01/09/2018 |
Primmune Therapeutics, Inc.
 Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy | Director Ejecutivo | 01/03/2019 |
Anavo Therapeutics BV
 Anavo Therapeutics BV BiotechnologyHealth Technology Operates as biotechnology company which develops therapeutic programs | Presidente | - |
McDermott Consulting
 McDermott Consulting Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 01/09/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Impact Biomedicines, Inc.
 Impact Biomedicines, Inc. Medical SpecialtiesHealth Technology Develops therapies for patients with life threatening malignancies | Presidente | 01/05/2018 |
| KALA BIO, INC. | Presidente | 07/08/2017 |
| ALLERGAN, INC. | Director/Miembro de la Junta | 01/05/2013 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Corporate Officer/Principal | 01/03/2005 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Cruz
 University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McDermott Consulting
McDermott Consulting Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Impact Biomedicines, Inc.
Impact Biomedicines, Inc. Medical SpecialtiesHealth Technology Develops therapies for patients with life threatening malignancies | Health Technology |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy | Commercial Services |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Anavo Therapeutics BV
Anavo Therapeutics BV BiotechnologyHealth Technology Operates as biotechnology company which develops therapeutic programs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
